MARCH 27
Days
- :
Hrs
- :
Min
- :
Sec
ePoster Gallery
P072: Military Insurance and Melanoma Outcomes in the National Cancer Database
Robert Chick M.D.
The Ohio State University
P073: Self-Perceived Barriers to Healthcare Experienced by Patients with Gastrointestinal Cancers
Samuel Butensky MD
Yale University School of Medicine, Department of Surgery
P074: Social vulnerability, but not rurality, is associated with receipt of guideline concordant care for pancreas cancer in North Carolina
Sarah Provencher
Duke University
P075: The Impact of Neighborhood Socioeconomic Disadvantage on Treatment and Outcomes for Resectable Gastric Cancer Patients in Florida: An Incidence-Based Retrospective Cohort Study
Anna Zamora BS
P076: The Melanoma Divide: Skin-deep Hispanic Health Disparities from Latin America to the United States
Gonzalo Ziegler Rodriguez MD, FACS
Clinica Ziegler
P077: Trends in Compliance with Updated Colorectal Cancer Screening Guidelines
Meredith Gunder
University of Louisville
P078: Two-Decade Trends in Gastrointestinal Neuroendocrine Tumors: Rising Incidence and Unresolved Disparities
Salvador Rodriguez Franco MD
University of Colorado Denver | Anschutz Medical Campus
P079: Age-Associated Alterations in Cytokine and Extracellular Matrix Remodeling in the Papillary Thyroid Cancer Tumor Microenvironment
Grace Thompson
University of Florida College of Medicine, Department of Surgery
P080: Novel Hsp90 inhibitor PC0 inhibits metastatic spread and overcomes cisplatin resistance in head and neck squamous cancers.
Chitra Subramanian
Carle Illinois College of Medicine
P081: 3D High-Density Collagen I Improves Modeling of Metastatic Pancreatic Cancer
Kim Nguyen-Ta MD, MS, MPH
University of California San Diego
P082: Actionable Targets for Small Molecule Inhibitor Therapy in Biliary Tract Cancers: An Analysis of American Association for Cancer (AACR) Project GENIE
Diamantis Tsilimigras MD, PhD
The Ohio State University
P083: Colorectal liver metastases in young patients: Management patterns and outcomes
Victoria Peters BS
UT Southwestern Medical Center
P084: Combined genomic, metabolomic and clinical outcome analysis identifies ATP6V1C1 and thonzonium as a novel target and potential treatment for HCC
Kathryn Tsai
Carle Illinois College of Medicine
P085: ctDNA as a novel biomarker of treatment efficacy in patients with unresectable colorectal liver metastases treated with hepatic arterial infusion
Annie Liu MD, PhD
Duke University Medical Center
P086: Detection of Volatile Organic Compounds as a Novel Biomarker for Pancreatic Adenocarcinoma
Kyle Stephens MD, MS
Division of Surgical Oncology, Department of Surgery, University of Louisville School of Medicine
P087: Developing a predictive model to identify patients with pancreatic cancer who are at risk of non-completion of curative-intent therapy.
Chad Cragle MD, PhD
Medical College of Wisconsin - - Miwaukee, WI
P088: Development of an APP-led Pancreatic Cyst Surveillance Clinic
Leslie Shaw PA-C
University Hospitals of Cleveland
P089: Do Plant-based Foods Impact the Risk of Developing Pancreatic Ductal Adenocarcinoma?
Parit Mavani MBBS
Emory University